No profile data available.
Skinvisible, Inc. (SKVI) is a healthcare company in the pharmaceutical administration systems industry, based in Las Vegas, United States, with about 2 full-time employees.
It reported revenue of $20,000 for fiscal year 2025, about flat from fiscal year 2024, and net income of -$1.06 million. Its market capitalization was $1.09 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas.
Skinvisible reported $20,000 in revenue for fiscal year 2025, about flat from $20,000 in fiscal year 2024.
$1.09 million as of October 8, 2026.
Listed companies of a similar size in the same industry (pharmaceutical administration systems) include Rani Therapeutics Holdings, Inc. (RANI), Lexaria Bioscience Corp. (LEXX), Xenetic Biosciences, Inc. (XBIO).